azd-5672 Report issue

Small molecule Experimental
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1
  • InChIKey: QOSMEMHKXNNIGG-SSEXGKCCSA-N
  • Mol. Mass: 639.83
  • ALogP: 4.07
  • ChEMBL Molecules:
    azd5672  
    azd-5363  
More Chemistry

Pharmacology

Alternative names

4-amino-n-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide | azd5363 | azd-5363 | azd5672 | azd 5672 | azd-5672 | n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide

Organizations (28)

Research & Development (28)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (43)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (43)


 

Adenocarcinoma (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Bile Duct Neoplasms (Phase 2)

Biomarkers (Phase 1)

BRCA1 Protein (Phase 1/Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 2)

Drug Evaluation (Phase 1)

Endometrial Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 1/Phase 2)

Glioma (Phase 2)

Hamartoma (Phase 1/Phase 2)

Healthy Volunteers (Phase 1)

Kidney Failure, Chronic (Phase 1)

Kidney Neoplasms (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 2)

Mutation (Phase 1/Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Pharmacokinetics (Phase 1)

Pharmacological and Toxicological Phenomena (Phase 1)

Prostatic Neoplasms (Phase 2)

Prostatic Neoplasms, Castration-Resistant (Phase 1)

Proteus Syndrome (Phase 1)

Proto-Oncogene Proteins c-akt (Phase 1)

PTEN Phosphohydrolase (Phase 1)

Skin Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Thyroid Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Uterine Neoplasms (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 28
  • # of Trial Organizations: 28

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue